Abstract
The increasing insight into pathomechanisms of dysregulated host response in several inflammatory diseases led to the implementation of the term “cytokine storm” in the literature more than 20 years ago. Direct toxic effects as well as indirect immunomodulatory mechanisms during cytokine storm have been described and were the basis for the rationale to use several substances and devices in life-threatening infections and hyperinflammatory states. Clinical trials have been performed, most of them in the form of minor, investigator-initiated protocols; major clinical trials focused mostly on sepsis and septic shock. The following review tries to summarize the background, pathophysiology, and results of clinical investigations that had implications for the development of therapeutic strategies and international guidelines for the management of hyperinflammation during syndromes of cytokine storm in adult patients, predominantly in septic shock.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference48 articles.
1. Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin.;A Taveira da Silva;N Engl J Med.,1993
2. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.;G Suntharalingam;N Engl J Med.,2006
3. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.;J Ferrara;Transplant Proc.,1993
4. [Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults].;N Aikawa;Nihon Geka Gakkai Zasshi.,1996
5. Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone.;M Alegre;J Immunol.,1991
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献